(KRN) Krones - Overview
Stock: Machines, Lines, Packaging, Filling, Intralogistics
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.87% |
| Yield on Cost 5y | 3.77% |
| Yield CAGR 5y | 156.57% |
| Payout Consistency | 83.6% |
| Payout Ratio | 38.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 22.4% |
| Relative Tail Risk | -7.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.30 |
| Alpha | -1.07 |
| Character TTM | |
|---|---|
| Beta | 0.448 |
| Beta Downside | 0.608 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.91% |
| CAGR/Max DD | 0.40 |
Description: KRN Krones January 10, 2026
Krones AG (XETRA:KRN) designs, develops, and manufactures equipment and complete production lines for the food and beverage sector, serving customers worldwide from its headquarters in Neutraubling, Germany.
The firm operates across three segments: Filling and Packaging Technology, which provides machinery for PET bottle production, filling, capping, labeling, inspection, palletising and recycling of used plastics; Process Technology, delivering systems for brewing, soft drinks, dairy, juice, alternative-protein drinks and water-treatment components; and Intralogistics, offering fully automated warehousing, order-picking, AGV-based material-flow solutions, and accompanying software and digitalization services.
Recent data (FY 2023) show revenue of roughly €4.2 billion with an EBIT margin near 9.5% and an order backlog of about €2 billion, indicating strong demand. Key economic drivers include tightening EU recycling regulations, rising consumer preference for sustainable packaging, and accelerated automation adoption in beverage production. The sector’s growth is further supported by expanding plant-based and functional drink categories, which increase demand for flexible, high-speed filling lines.
For a deeper quantitative assessment, you might explore Krones’ metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 289.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -2.57 > 1.0 |
| NWC/Revenue: 16.45% < 20% (prev 15.18%; Δ 1.27% < -1%) |
| CFO/TA 0.08 > 3% & CFO 401.4m > Net Income 289.6m |
| Net Debt (-361.2m) to EBITDA (604.4m): -0.60 < 3 |
| Current Ratio: 1.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.6m) vs 12m ago -0.04% < -2% |
| Gross Margin: 52.35% > 18% (prev 0.34%; Δ 5201 % > 0.5%) |
| Asset Turnover: 118.2% > 50% (prev 113.1%; Δ 5.09% > 0%) |
| Interest Coverage Ratio: 4252 > 6 (EBITDA TTM 604.4m / Interest Expense TTM 100.0k) |
Altman Z'' 3.54
| A: 0.19 (Total Current Assets 3.25b - Total Current Liabilities 2.34b) / Total Assets 4.82b |
| B: 0.32 (Retained Earnings 1.52b / Total Assets 4.82b) |
| C: 0.09 (EBIT TTM 425.2m / Avg Total Assets 4.68b) |
| D: 0.64 (Book Value of Equity 1.78b / Total Liabilities 2.79b) |
| Altman-Z'' Score: 3.54 = A |
Beneish M -3.34
| DSRI: 0.97 (Receivables 1.97b/1.88b, Revenue 5.53b/5.12b) |
| GMI: 0.65 (GM 52.35% / 34.03%) |
| AQI: 0.99 (AQ_t 0.15 / AQ_t-1 0.15) |
| SGI: 1.08 (Revenue 5.53b / 5.12b) |
| TATA: -0.02 (NI 289.6m - CFO 401.4m) / TA 4.82b) |
| Beneish M-Score: -3.34 (Cap -4..+1) = AA |
What is the price of KRN shares?
Over the past week, the price has changed by +0.29%, over one month by -1.00%, over three months by +6.29% and over the past year by +8.27%.
Is KRN a buy, sell or hold?
What are the forecasts/targets for the KRN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 150.3 | 8.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 155.1 | 11.9% |
KRN Fundamental Data Overview February 03, 2026
P/E Trailing = 15.0709
P/E Forward = 21.0084
P/S = 0.7813
P/B = 2.1775
P/EG = 2.4
Revenue TTM = 5.53b EUR
EBIT TTM = 425.2m EUR
EBITDA TTM = 604.4m EUR
Long Term Debt = 300.0k EUR (from longTermDebt, last quarter)
Short Term Debt = 45.4m EUR (from shortTermDebt, last quarter)
Debt = 182.3m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -361.2m EUR (from netDebt column, last quarter)
Enterprise Value = 4.19b EUR (4.37b + Debt 182.3m - CCE 362.8m)
Interest Coverage Ratio = 4252 (Ebit TTM 425.2m / Interest Expense TTM 100.0k)
EV/FCF = 20.40x (Enterprise Value 4.19b / FCF TTM 205.1m)
FCF Yield = 4.90% (FCF TTM 205.1m / Enterprise Value 4.19b)
FCF Margin = 3.71% (FCF TTM 205.1m / Revenue TTM 5.53b)
Net Margin = 5.24% (Net Income TTM 289.6m / Revenue TTM 5.53b)
Gross Margin = 52.35% ((Revenue TTM 5.53b - Cost of Revenue TTM 2.63b) / Revenue TTM)
Gross Margin QoQ = 52.97% (prev 54.74%)
Tobins Q-Ratio = 0.87 (Enterprise Value 4.19b / Total Assets 4.82b)
Interest Expense / Debt = 0.05% (Interest Expense 100.0k / Debt 182.3m)
Taxrate = 29.86% (28.9m / 96.8m)
NOPAT = 298.2m (EBIT 425.2m * (1 - 29.86%))
Current Ratio = 1.39 (Total Current Assets 3.25b / Total Current Liabilities 2.34b)
Debt / Equity = 0.09 (Debt 182.3m / totalStockholderEquity, last quarter 2.03b)
Debt / EBITDA = -0.60 (Net Debt -361.2m / EBITDA 604.4m)
Debt / FCF = -1.76 (Net Debt -361.2m / FCF TTM 205.1m)
Total Stockholder Equity = 1.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.19% (Net Income 289.6m / Total Assets 4.82b)
RoE = 14.66% (Net Income TTM 289.6m / Total Stockholder Equity 1.98b)
RoCE = 21.52% (EBIT 425.2m / Capital Employed (Equity 1.98b + L.T.Debt 300.0k))
RoIC = 61.80% (NOPAT 298.2m / Invested Capital 482.5m)
WACC = 7.27% (E(4.37b)/V(4.55b) * Re(7.57%) + D(182.3m)/V(4.55b) * Rd(0.05%) * (1-Tc(0.30)))
Discount Rate = 7.57% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -0.02%
[DCF Debug] Terminal Value 77.08% ; FCFF base≈246.8m ; Y1≈192.9m ; Y5≈124.7m
Fair Price DCF = 96.39 (EV 2.68b - Net Debt -361.2m = Equity 3.05b / Shares 31.6m; r=7.27% [WACC]; 5y FCF grow -26.03% → 2.90% )
EPS Correlation: 76.49 | EPS CAGR: 6.13% | SUE: -0.57 | # QB: 0
Revenue Correlation: 94.37 | Revenue CAGR: 8.78% | SUE: -0.30 | # QB: 0
EPS next Year (2026-12-31): EPS=10.61 | Chg30d=-0.146 | Revisions Net=+1 | Growth EPS=+7.7% | Growth Revenue=+4.4%